Testosterone drugs heavily advertised by pharmaceutical companies for men who have “Low T,” or low testosterone, to fight symptoms that come naturally as a man ages, have been linked to serious heart risks and are among the top Dangerous Drug & Medical Device Lawsuits cited by the Drug Lawsuit Source.
“Recent medical and scientific studies have shown that there are several serious health risks to men caused by these drugs,” the website warns. “In fact, recent studies have identified a link between testosterone replacement therapy and increased risk of heart attacks. Other side effects of the drugs include non-fatal myocardial infarction, strokes, blood clots, enlarged breasts and mood swings. As a result of these conditions, death can occur.”
Testosterone replacement therapies are available in patches, topical solutions, topical gels, tablets, injections and pellets. Brand names include Androgel, Axiron, Bio-T-Gel, Delatestryl, Depo-Testosterone, Fortesta, Striant, Testim and Testopel. These prescription drugs are intended to increase testosterone levels in men with hypogonadism, a condition in which men do not produce enough of the hormone due to disease or injury, resulting in symptoms such as low libido, muscle loss, and fertility issues.
Testosterone levels naturally decrease as a man ages. Drug companies have aggressively advertised testosterone as a treatment for older men with low testosterone levels. However, studies show that boosting testosterone levels in men with age-related hypogonadism may expose them to serious health risks such as heart attacks, strokes and death.
Manufacturers of testosterone replacement products are facing a growing number of lawsuits alleging the companies did not adequately warn doctors or the public of the potential heart risks associated with testosterone treatment.
Source: Drug Lawsuit Source